Medical Developments International Limited
MVP
Clasificación en acciones
#27443
Medical Developments International Limited (MDIL) specializes in the... Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
Precio por acción
$0.27858749
Capitalización bursátil
$31.39M
Cambio (1 día)
-1.25%
Cambio (1 año)
-13.10%
País
AU
Comercio Medical Developments International Limited (MVP)
Categoría
Healthcare
Capitalización de mercado de Medical Developments International Limited(MVP)
Capitalización bursátil: $31.39M
A fecha de October 2026, Medical Developments International Limited tiene una capitalización de mercado de $31.39M. Esto convierte a Medical Developments International Limited en la 27443rd empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Medical Developments International Limited desde 2020 hasta 2026
MVP en comparación con los más populares 5 títulos stocks
